Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 9.01% vs -22.01% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -25.00% vs -2.91% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 5.63% vs -41.91% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -25.10% vs 2.54% in Mar 2024
Compare Profit and Loss Results of M K Proteins
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
267.00
734.00
-467.00
-63.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
267.00
734.00
-467.00
-63.62%
Expenditure (Ex Depriciation)
Stock Adjustments
21.00
4.00
17.00
425.00%
Raw Materials Consumed
218.00
626.00
-408.00
-65.18%
Power & Fuel Cost
8.00
10.00
-2.00
-20.00%
Employee Cost
2.00
20.00
-18.00
-90.00%
Operating Expenses
2.00
10.00
-8.00
-80.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
8.00
-8.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
255.00
686.00
-431.00
-62.83%
Operating Profit (PBDIT) excl Other Income
12.00
48.00
-36.00
-75.00%
Other Income
0.00
7.00
-7.00
-100.00%
Operating Profit (PBDIT)
12.00
55.00
-43.00
-78.18%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
11.00
55.00
-44.00
-80.00%
Depreciation
0.00
5.00
-5.00
-100.00%
Profit Before Taxation & Exceptional Items
11.00
49.00
-38.00
-77.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
11.00
49.00
-38.00
-77.55%
Provision for Tax
3.00
12.00
-9.00
-75.00%
Profit After Tax
8.00
37.00
-29.00
-78.38%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23.00
147.00
-124.00
-84.35%
Profit Available for appropriations
31.00
184.00
-153.00
-83.15%
Appropriations
31.00
184.00
-153.00
-83.15%
Equity Dividend (%)
0%
30%
-30.00
Earnings Per Share
0.22
7.39
-7.17
-97.02%
Profit And Loss - Net Sales
Net Sales 267.71 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.01% vs -22.01% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -25.00% vs -2.91% in Mar 2024
Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5.63% vs -41.91% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 8.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -25.10% vs 2.54% in Mar 2024
